All investigators
15 investigators· 6 rising
| Fit | Investigator | Focus | Enroll | Vel/yr | Status |
|---|---|---|---|---|---|
92 | Dr. Amelia ParkRising Samsung Medical Center · Seoul, KR | Phase 3NSCLC | 127 | 24 | Responsive |
91 | Dr. Priya RamanRising Massachusetts General Hospital · Boston, MA, US | Phase 3NeurologyAlzheimer's | 310 | 38 | Responsive |
89 | Dr. Sarah GoldbergRising Sheba Medical Center · Tel Aviv, IL | Phase 3OncologyMelanoma | 155 | 21 | Responsive |
88 | Dr. Aisha MbekiRising Desmond Tutu HIV Foundation · Cape Town, ZA | Phase 3Infectious DiseaseHIV | 2400 | 410 | Responsive |
85 | Dr. Marcus Chen UCSF Medical Center · San Francisco, CA, US | Phase 3CardiologyHeart Failure | 198 | 27 | Responsive |
84 | Dr. Isabella Romano Ospedale San Raffaele · Milan, IT | Phase 3NeurologyMultiple Sclerosis | 172 | 24 | Responsive |
82 | Dr. Hiroshi Tanaka National Cancer Center Hospital · Tokyo, JP | Phase 2OncologyGastric Cancer | 134 | 22 | Responsive |
81 | Dr. Wei Zhang Fudan University Shanghai Cancer Center · Shanghai, CN | Phase 3OncologyHepatocellular Carcinoma | 225 | 34 | Responsive |
80 | Dr. Emma Thompson Imperial College Healthcare NHS Trust · London, GB | Phase 3RheumatologySystemic Lupus Erythematosus | 118 | 18 | Responsive |
78 | Dr. Rajesh Patel Kokilaben Dhirubhai Ambani Hospital · Mumbai, IN | Phase 3EndocrinologyType 2 Diabetes | 870 | 145 | Responsive |
74 | Dr. James Whitfield483 MD Anderson Cancer Center · Houston, TX, US | Phase 2Oncology | 82 | 17 | Pending |
71 | Dr. Carlos MendozaRising A.C. Camargo Cancer Center · São Paulo, BR | Phase 2Pediatric OncologyNeuroblastoma | 54 | 9 | Pending |
69 | Dr. Sofia CostaRising Champalimaud Foundation · Lisbon, PT | Phase 1Rare Disease | 41 | 11 | Responsive |
66 | Dr. Elena Volkov N.N. Blokhin Cancer Research Center · Moscow, RU | Phase 2HematologyAML | 62 | 14 | Pending |
63 | Dr. David Okonkwo483 UPMC Presbyterian · Pittsburgh, PA, US | Phase 2NeurologyTraumatic Brain Injury | 88 | 12 | Overbooked |